Chroma Medicine is a pioneering biotech company based in Boston, MA, dedicated to revolutionizing the treatment of diseases through the development of single-dose genomic medicines. By harnessing the power of epigenetics, nature's innate mechanism for gene regulation, Chroma aims to unlock a vast landscape of genomic therapeutics, offering unparalleled control of gene expression without altering the DNA sequence.
With a team of bold and creative experts, Chroma Medicine is at the forefront of genomic medicine, building on groundbreaking research to develop an entirely new class of therapeutics. Their innovative approach, which does not involve cutting or altering the DNA sequence, promises to reshape the future of medicine by providing durable changes in gene expression. Through their breakthrough discoveries, Chroma Medicine is reimagining genome regulation and paving the way for a bright future in genomic medicine.
Generated from the website